Evidence map›Paper›PMID 28965765›Full record

ArticleCell stem cell2017

MYC Controls Human Pluripotent Stem Cell Fate Decisions through Regulation of Metabolic Flux.

Timothy S Cliff, Tianming Wu, Benjamin R Boward, Amelia Yin, Hang Yin, John N Glushka, James H Prestegaard, Stephen Dalton

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Timothy S CliffDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Center for Molecular Medicine, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA.
Tianming WuDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Center for Molecular Medicine, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA.
Benjamin R BowardDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Center for Molecular Medicine, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA.
Amelia YinDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Center for Molecular Medicine, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA.
Hang YinDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Center for Molecular Medicine, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA.
John N GlushkaDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602, USA.
James H PrestegaardDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602, USA.
Stephen DaltonDepartment of Biochemistry and Molecular Biology, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA; Center for Molecular Medicine, University of Georgia, 500 D.W. Brooks Drive, Athens, GA 30602, USA. Electronic address: sdalton@uga.edu.
University of Georgia · US

Funding

UNDERSTANDING MECHANISMS OF hESC SELF-RENEWAL AND CELL FATE COMMITMENTP01GM085354 · NIGMS · UNIVERSITY OF GEORGIA · PI DALTON, STEPHEN · 2008 to 2018
$18.3M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Impacts of hypoxia and hypoxia-induced factors on skeletal muscle repair and muscle stem cellsR01AR070178 · NIAMS · UNIVERSITY OF GEORGIA · PI YIN, HANG · 2016 to 2020
$1.6M
Electronics Consoles for Biomolecular NMRS10RR027097 · NCRR · UNIVERSITY OF GEORGIA · PI URBAUER, JEFFREY L · 2011 to 2011
$364k
NCRR NIH HHS S10 RR027097NIAMS NIH HHS R01 AR070178NIGMS NIH HHS P01 GM085354NIGMS NIH HHS P41 GM103390
6 · The paper itself

Abstract

As human pluripotent stem cells (hPSCs) exit pluripotency, they are thought to switch from a glycolytic mode of energy generation to one more dependent on oxidative phosphorylation. Here we show that, although metabolic switching occurs during early mesoderm and endoderm differentiation, high glycolytic flux is maintained and, in fact, essential during early ectoderm specification. The elevated glycolysis observed in hPSCs requires elevated MYC/MYCN activity. Metabolic switching during endodermal and mesodermal differentiation coincides with a reduction in MYC/MYCN and can be reversed by ectopically restoring MYC activity. During early ectodermal differentiation, sustained MYCN activity maintains the transcription of "switch" genes that are rate-limiting for metabolic activity and lineage commitment. Our work, therefore, shows that metabolic switching is lineage-specific and not a required step for exit of pluripotency in hPSCs and identifies MYC and MYCN as developmental regulators that couple metabolism to pluripotency and cell fate determination.

Indexed as

Cell LineageMetabolic Flux AnalysisCell CycleCell DifferentiationGerm LayersGlycolysisHumansMagnetic Resonance SpectroscopyModels, BiologicalN-Myc Proto-Oncogene ProteinPluripotent Stem CellsProto-Oncogene Proteins c-mycMYCN protein, humanN-Myc Proto-Oncogene ProteinProto-Oncogene Proteins c-myccell fatedifferentiationgerm layersmetabolic fluxmetabolic switchingMYCpluripotency

Identifiers

PMID28965765
PMCPMC5644510
OpenAlexW2759135838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.